Morning Headlines 11/29/16
Republicans reach deal to pass Cures Act by end of year, but Democrats pushing for changes
The House will vote Wednesday on a final version of the 21st Century Cures Act, a $6.3 billion piece of legislation that will target opioid addiction, fund Obama administration research programs for the next 10 years, and speed federal approval of new drugs and devices.
CMS’ star ratings for hospitals linked to social, economic factors
A new JAMA study finds that a hospital’s CMS star rating is “heavily influenced by its location’s socio-economic conditions,” reinforcing longstanding concerns voiced by industry stakeholders.
Theranos Sued for Alleged Fraud by Robertson Stephens Co-Founder Colman
Lawsuits continue to pile up for Theranos, with investment firm Robertson Stephens & Co founder Robert Colman accusing the company of making false and misleading claims about operations and technology during its investment talks.
Former conman and world renown authority on forgery and fraud, Frank Abagnale, will speak at HIMSS17 at a session called Stealing Your Life that will address data breaches and identify theft within the healthcare industry.
With McGraw’s new position at Transcarent, it seems like Glen Tullman might be getting the Allscripts band back together.